Search hospitals > Virginia > Charlottesville

Charlottesville Medical Research

Claim this profile
Charlottesville, Virginia 22911
Global Leader in Migraine
Global Leader in Osteoarthritis
Conducts research for Vestibular Migraine
Conducts research for Osteoarthritis Treatment Costs
Conducts research for Flu
115 reported clinical trials
2 medical researchers
Photo of Charlottesville Medical Research in CharlottesvillePhoto of Charlottesville Medical Research in Charlottesville

Summary

Charlottesville Medical Research is a medical facility located in Charlottesville, Virginia. This center is recognized for care of Migraine, Osteoarthritis, Vestibular Migraine, Osteoarthritis Treatment Costs, Flu and other specialties. Charlottesville Medical Research is involved with conducting 115 clinical trials across 110 conditions. There are 2 research doctors associated with this hospital, such as James Clark and Daniel Pambianco, MD.

Top PIs

Clinical Trials running at Charlottesville Medical Research

Flu
Gout
Obesity
Hyperuricemia
Coronavirus
Influenza
Acid Reflux
Type 2 Diabetes
Vestibular Migraine
Migraine
Image of trial facility.

Adjuvanted Flu Vaccine

for Flu

This Phase 3 study is a randomized, observer-blind study of MF59-adjuvanted influenza vaccine (aQIV or aTIV) compared with a non-adjuvanted influenza vaccine (QIV or TIV) in adults ≥65 years of age. The aim of the study is to evaluate MF59-adjuvanted influenza vaccine compared with non-adjuvanted influenza vaccine in the prevention of reverse transcription-polymerase chain reaction (RT-PCR)-confirmed influenza A and/or B in subjects ≥65 years of age.
Recruiting2 awards Phase 31 criteria
Image of trial facility.

Flu and COVID-19 Vaccines

for Coronavirus and Influenza

The purpose of this study is to learn about how the flu and COVID vaccines act when given alone or when mixed together. This study is seeking healthy participants aged 18 or older. All participants in this study will receive only 1 shot to their arm, either a flu or COVID vaccine, alone or mixed. Participants will take part in this study for about 6 months, and participants will need to visit the clinical study site at least 4 times.
Recruiting1 award Phase 1 & 2
Image of trial facility.

CD388

for Flu Prevention

The purpose of this study is to evaluate how well CD388 works in preventing symptomatic laboratory-confirmed influenza infections, as compared to placebo, when given as a single dose via 3 subcutaneous (SQ) injections to adult and adolescent participants who are at higher risk of developing influenza complications, and to evaluate the safety and tolerability of CD388, as compared to placebo.
Recruiting1 award Phase 32 criteria

Similar Hospitals nearby

Frequently asked questions

What kind of research happens at Charlottesville Medical Research?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security